The goal of the work proposed in this application is to determine the overall regulation of fatty acid metabolism in cardiac muscle. Because Coenzyme A (CoA) and carnitine are essential cofactors of fatty acid metabolism, the work has, in recent years, been directed toward determining the regulation of tissue levels and cellular distribution of these cofactors. CoA is synthesized in the cytosol from pantothenic acid which enters the cells by an active-Na+- dependent symport system. Regulation of CoA synthesis occurs at the level of the cystoloic pantothenate kinase. However, about 95% of the total cellular CoA is located in mitochondria. Much of the proposed work relates to understanding the control of this CoA synthetic, cellular distribution pathway. 1. The pantothenate transport system is poorly characterized. We propose to study the regulation of this transporter using perfused hearts, isolated myocytes, purified sarcolemmal membrane vesicles and isolated, reconstituted transporter. Pantothenate transport in heart muscle is decreased by 80-90% while transporter in liver is increased several fold in diabetic animals. We plan to investigate the mechanism of these effects. 2. The decline in pantothenate transport causes intracellular pantothenic acid concentration to decrease and, in chronic diabetes, pantothenic acid concentration may become limiting for CoA synthesis in heart muscle. We plan to determine the physiological consequences of decreased pantothenate transport on CoA synthesis, CoA levels and cellular metabolism. 3. The functional pathway of CoA degradation is not known. We plan to define the pathway and determine its regulation in intact tissue, purified membranes and isolated mitochondria. 4. We will characterize and determine the regulation of the newly discovered system for CoA transport into mitochondria. 5. Carnitine is not synthesized in heart muscle, but is taken up from blood by a Na+- symport system similar to that for pantothenic acid. We plan to begin studies on the isolation and purification of the Na+-symport systems for pantothenic acid and carnitine by first developing assays for the transporters using either specific binding to purified proteins or transport activity in reconstituted lipid vesicles.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Biochemistry Study Section (BIO)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of South Alabama
Schools of Allied Health Profes
United States
Zip Code
Tahiliani, A G; Keene, T; Kaplan, R S (1992) Characterization of the inhibitor sensitivity of the coenzyme A transport system in isolated rat heart mitochondria. J Bioenerg Biomembr 24:635-40
Tahiliani, A G (1991) Evidence for net uptake and efflux of mitochondrial coenzyme A. Biochim Biophys Acta 1067:29-37
Tahiliani, A G; Beinlich, C J (1991) Pantothenic acid in health and disease. Vitam Horm 46:165-228
Beinlich, C J; Naumovitz, R D; Song, W O et al. (1990) Myocardial metabolism of pantothenic acid in chronically diabetic rats. J Mol Cell Cardiol 22:323-32
Beinlich, C J; Robishaw, J D; Neely, J R (1989) Metabolism of pantothenic acid in hearts of diabetic rats. J Mol Cell Cardiol 21:641-9
Tahiliani, A G (1989) Dependence of mitochondrial coenzyme A uptake on the membrane electrical gradient. J Biol Chem 264:18426-32
Tahiliani, A G; Neely, J R (1987) Mitochondrial synthesis of coenzyme A is on the external surface. J Mol Cell Cardiol 19:1161-7
Tahiliani, A G; Neely, J R (1987) A transport system for coenzyme A in isolated rat heart mitochondria. J Biol Chem 262:11607-10